Enanta Pharmaceuticals In... (ENTA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.94
0.10 (2.07%)
At close: Jan 15, 2025, 12:35 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
PE Ratio | -1.89 | -1.75 | -8.78 | -14.51 | -25.24 | 25.37 | 24.14 | 50.38 | 23.25 | 8.54 | 21.09 | 23.30 | 0.93 | 0.85 | 27.70 |
PS Ratio | 3.24 | 2.96 | 12.40 | 11.80 | 7.45 | 5.73 | 8.41 | 8.68 | 5.71 | 4.19 | 15.21 | 7.00 | 0.48 | 0.48 | 9.62 |
PB Ratio | 1.70 | 1.08 | 3.33 | 2.87 | 2.00 | 2.54 | 4.41 | 2.96 | 1.87 | 2.86 | 4.89 | 2.03 | 0.45 | -0.15 | n/a |
P/FCF Ratio | -2.27 | -2.09 | -12.3 | -16.2 | 161.77 | 17.83 | 66.19 | 17.79 | 16.21 | 9.08 | 37.93 | 22.33 | 0.89 | 0.84 | -21.44 |
P/OCF Ratio | -2.78 | -2.27 | -12.61 | -16.37 | 128.79 | 16.47 | 59.44 | 16.95 | 14.07 | 8.80 | 35.99 | 21.06 | 0.88 | 0.83 | -21.52 |
OCF/S Ratio | -1.16 | -1.3 | -0.98 | -0.72 | 0.06 | 0.35 | 0.14 | 0.51 | 0.41 | 0.48 | 0.42 | 0.33 | 0.54 | 0.57 | -0.45 |
Debt / Equity Ratio | 0.43 | 0.12 | 0.08 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | n/a |
Quick Ratio | 5.21 | 6.73 | 10.45 | 9.85 | 18.08 | 17.77 | 23.74 | 11.33 | 29.43 | 25.45 | 22.75 | 23.14 | 8.25 | 11.68 | n/a |
Current Ratio | 5.21 | 6.73 | 10.45 | 8.82 | 18.08 | 17.77 | 23.74 | 11.33 | 29.43 | 25.45 | 22.75 | 23.14 | 8.25 | 11.68 | n/a |
Asset Turnover | 0.18 | 0.17 | 0.23 | 0.22 | 0.25 | 0.42 | 0.50 | 0.31 | 0.31 | 0.65 | 0.31 | 0.27 | 0.80 | 1.60 | n/a |
Interest Coverage | -11.12 | -26.65 | -78.73 | n/a | n/a | 4.17 | 18.20 | 615.35 | 685.36 | 15.52K | 1.05K | 291.26 | n/a | 8.00 | n/a |
Return on Equity (ROE) | -0.9 | -0.62 | -0.38 | -0.2 | -0.08 | 0.10 | 0.18 | 0.06 | 0.08 | 0.33 | 0.23 | 0.09 | 0.49 | -0.18 | n/a |
Return on Assets (ROA) | -0.31 | -0.29 | -0.32 | -0.18 | -0.07 | 0.09 | 0.17 | 0.05 | 0.08 | 0.32 | 0.22 | 0.08 | 0.41 | 0.89 | n/a |
Return on Capital (ROIC) | -0.38 | -0.34 | -0.36 | -0.27 | -0.09 | 0.08 | 0.22 | 0.08 | 0.11 | 0.52 | 0.13 | 0.08 | 0.46 | 1.06 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | 100.00% | 96.55% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Net Profit Margin | -171.58% | -168.95% | -141.31% | -81.38% | -29.53% | 22.60% | 34.82% | 17.23% | 24.55% | 49.10% | 72.14% | 30.03% | 51.31% | 55.66% | 34.72% |
Pretax Profit Margin | -174.15% | -165.39% | -141.82% | -110.82% | -28.59% | 22.20% | 45.07% | 26.21% | 36.89% | 77.98% | 40.36% | 30.03% | 51.31% | 55.66% | 34.03% |
Operating Profit Margin | -179.92% | -173.23% | -143.74% | -112.88% | -34% | 17.90% | 42.75% | 23.94% | 34.94% | 77.17% | 39.77% | 28.17% | 51.05% | 60.41% | 30.50% |
FCF Margin | -142.99% | -141.67% | -100.87% | -72.88% | 4.61% | 32.16% | 12.70% | 48.77% | 35.20% | 46.21% | 40.11% | 31.34% | 53.64% | 56.29% | -44.86% |
EBITDA Margin | -154.52% | -155.9% | -138.36% | -107.39% | -31.02% | 19.49% | 43.97% | 26.02% | 36.82% | 77.57% | 40.50% | 28.86% | 51.72% | 64.40% | 36.46% |